1. Home
  2. MXCT vs VATE Comparison

MXCT vs VATE Comparison

Compare MXCT & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.07

Market Cap

112.5M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$8.18

Market Cap

110.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
VATE
Founded
1999
1994
Country
United States
United States
Employees
N/A
3738
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
112.5M
110.8M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
MXCT
VATE
Price
$1.07
$8.18
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.0M
93.0K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,026,000.00
$1,246,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.55
52 Week Low
$0.64
$3.75
52 Week High
$2.19
$21.30

Technical Indicators

Market Signals
Indicator
MXCT
VATE
Relative Strength Index (RSI) 36.81 30.19
Support Level $0.97 $4.38
Resistance Level $1.16 $13.40
Average True Range (ATR) 0.08 0.72
MACD -0.03 0.05
Stochastic Oscillator 7.00 25.54

Price Performance

Historical Comparison
MXCT
VATE

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

Share on Social Networks: